OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead's Drug Candidate

Core Insights - OncoNano Medicine, Inc. has announced a research collaboration with Gilead Sciences, Inc. to evaluate OncoNano's ON-BOARD encapsulation technology with Gilead's drug candidate [1] Group 1: Collaboration Details - The collaboration aims to assess the stability, selectivity, and efficacy of Gilead's drug candidate when encapsulated using OncoNano's ON-BOARD technology [1] - This partnership highlights the broad applicability of OncoNano's technology in enhancing drug delivery systems [1]